Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 21935436)

1.

Chemokines and their receptors play important roles in the development of hepatocellular carcinoma.

Liang CM, Chen L, Hu H, Ma HY, Gao LL, Qin J, Zhong CP.

World J Hepatol. 2015 Jun 8;7(10):1390-402. doi: 10.4254/wjh.v7.i10.1390. Review.

2.

Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway.

Yu Q, Lou XM, He Y.

PLoS One. 2015 Mar 13;10(3):e0120855. doi: 10.1371/journal.pone.0120855. eCollection 2015.

3.

Skewed T-helper (Th)1/2- and Th17/T regulatory‑cell balances in patients with renal cell carcinoma.

Li L, Yang C, Zhao Z, Xu B, Zheng M, Zhang C, Min Z, Guo J, Rong R.

Mol Med Rep. 2015 Feb;11(2):947-53. doi: 10.3892/mmr.2014.2778. Epub 2014 Oct 27.

4.

MicroRNAs expression profile in CCR6(+) regulatory T cells.

Zhao J, Li Y, Hu Y, Chen C, Zhou Y, Tao Y, Guo M, Qin N, Xu L.

PeerJ. 2014 Sep 18;2:e575. doi: 10.7717/peerj.575. eCollection 2014.

5.

The role of chemoattractant receptors in shaping the tumor microenvironment.

Zhou J, Xiang Y, Yoshimura T, Chen K, Gong W, Huang J, Zhou Y, Yao X, Bian X, Wang JM.

Biomed Res Int. 2014;2014:751392. doi: 10.1155/2014/751392. Epub 2014 Jul 10. Review.

6.

Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients.

Chen L, Ma H, Hu H, Gao L, Wang X, Ma J, Gao Q, Liu B, Zhou G, Liang C.

BMC Cancer. 2014 Jul 7;14:489. doi: 10.1186/1471-2407-14-489.

7.

Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions.

Hato T, Goyal L, Greten TF, Duda DG, Zhu AX.

Hepatology. 2014 Nov;60(5):1776-82. doi: 10.1002/hep.27246. Epub 2014 Sep 26. Review.

PMID:
24912948
8.

Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development.

Tu T, Budzinska MA, Maczurek AE, Cheng R, Di Bartolomeo A, Warner FJ, McCaughan GW, McLennan SV, Shackel NA.

Int J Mol Sci. 2014 May 27;15(6):9422-58. doi: 10.3390/ijms15069422. Review.

9.

Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: a meta analysis.

Huang Y, Liao H, Zhang Y, Yuan R, Wang F, Gao Y, Wang P, Du Z.

PLoS One. 2014 May 14;9(5):e94376. doi: 10.1371/journal.pone.0094376. eCollection 2014.

10.

ZIP4, a novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation.

Xu X, Guo HJ, Xie HY, Li J, Zhuang RZ, Ling Q, Zhou L, Wei XY, Liu ZK, Ding SM, Chen KJ, Xu ZY, Zheng SS.

Int J Biol Sci. 2014 Feb 11;10(3):245-56. doi: 10.7150/ijbs.7401. eCollection 2014.

11.

Role of lymphocytes in liver cancer.

Mossanen JC, Tacke F.

Oncoimmunology. 2013 Nov 1;2(11):e26468. Epub 2013 Oct 21. Review.

12.

CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis.

Affò S, Morales-Ibanez O, Rodrigo-Torres D, Altamirano J, Blaya D, Dapito DH, Millán C, Coll M, Caviglia JM, Arroyo V, Caballería J, Schwabe RF, Ginès P, Bataller R, Sancho-Bru P.

Gut. 2014 Nov;63(11):1782-92. doi: 10.1136/gutjnl-2013-306098. Epub 2014 Jan 10.

13.

Transcriptional heterogeneity of IgM+ cells in rainbow trout (Oncorhynchus mykiss) tissues.

Abós B, Castro R, Pignatelli J, Luque A, González L, Tafalla C.

PLoS One. 2013 Dec 6;8(12):e82737. doi: 10.1371/journal.pone.0082737. eCollection 2013.

14.

Increased frequency of CD4+ CD25+ FOXP3+ cells correlates with the progression of 4-nitroquinoline1-oxide-induced rat tongue carcinogenesis.

Zhao J, Wang Z, Han J, Qiu X, Pan J, Chen J.

Clin Oral Investig. 2014 Sep;18(7):1725-30. doi: 10.1007/s00784-013-1146-5. Epub 2013 Nov 22.

15.

Pubertal high fat diet: effects on mammary cancer development.

Zhao Y, Tan YS, Aupperlee MD, Langohr IM, Kirk EL, Troester MA, Schwartz RC, Haslam SZ.

Breast Cancer Res. 2013;15(5):R100.

16.

The role of chemokines in acute and chronic hepatitis C infection.

Fahey S, Dempsey E, Long A.

Cell Mol Immunol. 2014 Jan;11(1):25-40. doi: 10.1038/cmi.2013.37. Epub 2013 Aug 19. Review.

17.

T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment.

Pedroza-Gonzalez A, Kwekkeboom J, Sprengers D.

Oncoimmunology. 2013 Jan 1;2(1):e22450.

18.

Hepatitis B surface antigen could contribute to the immunopathogenesis of hepatitis B virus infection.

Kondo Y, Ninomiya M, Kakazu E, Kimura O, Shimosegawa T.

ISRN Gastroenterol. 2013;2013:935295. doi: 10.1155/2013/935295. Epub 2013 Jan 16.

19.

Inflammatory immune responses in tumor microenvironment and metastasis of hepatocellular carcinoma.

Qin LX.

Cancer Microenviron. 2012 Dec;5(3):203-9. doi: 10.1007/s12307-012-0111-1. Epub 2012 Jun 8.

20.

Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections.

Stauffer JK, Scarzello AJ, Jiang Q, Wiltrout RH.

Hepatology. 2012 Oct;56(4):1567-74. doi: 10.1002/hep.25674. Epub 2012 Sep 11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk